PER 4.94% 8.5¢ percheron therapeutics limited

anp in the big picture of isis?

  1. 9,102 Posts.
    lightbulb Created with Sketch. 386
    From ISIS recent presentation -

    KYNAMRO is in many ways a validation of everything
    we have created at Isis – a unique drug discovery platform
    (antisense), a maturing pipeline, and a business strategy
    that has made this exciting time in Isis’ history possible.

    Our pipeline is broad, deep and growing, and it represents
    the future beyond KYNAMRO.


    The success of KYNAMRO combined
    with the success of many of the other drugs in our pipeline
    gives us great optimism that we can bring our novel
    business model to fruition.


 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.5¢
Change
0.004(4.94%)
Mkt cap ! $76.63M
Open High Low Value Volume
8.1¢ 8.5¢ 8.1¢ $46.54K 563.7K

Buyers (Bids)

No. Vol. Price($)
2 164616 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.5¢ 100110 1
View Market Depth
Last trade - 15.55pm 28/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.